NEUROTOXIC MECHANISMS OF DEGENERATION IN MOTOR NEURON DISEASES*

REFERENCES

• Olney J. W., Sharpe L. G. Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science 1969; 166: 386–388
   PubMed Web of Science ®Google Scholar
• Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1987; 1: 623–634
   Web of Science ®Google Scholar
• Spencer P. S., Roy D. N., Ludolph A. C., Hugon J., Dwivedi M. P., Schaumburg H. H. Lathyrism: Evidence for role of the neuroexcitatory aminoacid BOAA. Lancet 1986; ii: 1066–1067
   Google Scholar
• Rosen R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H.-X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S. M., Berger R., Tanzi R. E., Halperin J., Herzfeldt B., van den Berg R., Hung W.-Y., Bird T., Deng G., Mulder D. W., Smyth C., Laing N. G., Soriano E. R., Pericak-Vance M. A., Haines J., Rouleau G. A., Gusella J. S., Horvitz H. R., Brown R. H., Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62
   PubMed Web of Science ®Google Scholar
• Casari G., De Fusco M., Ciarmatori S., Zeviani M., Mora M., Fernandez P., De Michele G., Filla A., Cocozza S., Marconi R., Durr A., Fontaine B., Ballabio A. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998; 93: 973–983
   PubMed Web of Science ®Google Scholar
• Weal H. V., Thomson A. M. Excitatory Amino Acids and Synaptic Transmission. Academic Press, London 1991
   Google Scholar
• Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci 1994; 17: 31–108
   PubMed Web of Science ®Google Scholar
• Geiger J. R., Melcher T, Koh D. S., Sakann B., Seeburg P. H., Jonas P., Monyer H. Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 1995; 15: 193–204
   PubMed Web of Science ®Google Scholar
• Sommer B., Kohler M., Sprengel R., Seeburg P. H. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 1991; 67: 11–19
   PubMed Web of Science ®Google Scholar
• Choi D. W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 1987; 7: 369–379
   PubMed Web of Science ®Google Scholar
• Nicotera P., Ankarcrona M., Bonfoco E., Orrenius S., Lipton S. A. Neuronal necrosis and apoptosis: Two distinct events induced by exposure to glutamate or oxidative stress. Adv. Neurol. 1997; 72: 95–101
   PubMedGoogle Scholar
• Choi D. W. Ischemia-induced neuronal apoptosis. Curr. Opin. Neurobiol. 1996; 6: 667–672
   PubMed Web of Science ®Google Scholar
• Simonian N. A., Coyle J. T. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 1996; 36: 83–106
   PubMed Web of Science ®Google Scholar
• Garcia-Segura L. M., Baetens D., Roth J., Norman A. W., Orci L. Immunohistochemical mapping of calcium-binding protein immunoreactivity in the rat central nervous system. Brain Res. 1984; 296: 75–86
   PubMed Web of Science ®Google Scholar
• Ince P., Stout N., Shaw P., Slade J., Hunziker W., Heizmann C. W., Baimbridge K. G. Parvalbumin and calbindin D-28k in the human motor system and in motor neuron disease. Neuropathol. Appl. Neurobiol. 1993; 19: 291–299
   PubMed Web of Science ®Google Scholar
• Beal M. F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann. Neurol. 1992; 31: 119–130
   PubMed Web of Science ®Google Scholar
• Albin R. L., Greenamyre J. T. Alternative excitotoxic hypotheses. Neurology 1992; 42: 733–739
   PubMed Web of Science ®Google Scholar
• Ludolph A. C., Riepe M., Ullrich K. Excitotoxicity, energy metabolism and neurodegeneration. J. Inherit. Metab. Dis. 1993; 16: 716–723
   PubMed Web of Science ®Google Scholar
• Spencer P. S., Allen R. G., Kisby G. E., Ludolph A. C. Excitotoxic disorders. Science 1990; 248: 144
   PubMed Web of Science ®Google Scholar
• Ludolph A. C., Hugon J., Dwivedi M. P., Schaumburg H. H., Spencer P. S. Studies on the aetiology and pathogenesis of motor neuron diseases. 1. Lathyrism: clinical findings in established cases. Brain 1987; 110: 149–165
   PubMed Web of Science ®Google Scholar
• Spencer P. S., Ludolph A. C., Kisby G. E. Are human neurodegenerative disorders linked to environmental chemicals with excitotoxic properties?. Ann. NY Acad. Sci. 1992; 648: 154–160
   PubMed Web of Science ®Google Scholar
• Ludolph A. C., Spencer P. S. Toxic models of upper motor neuron disease. J. Neurol. Sci. 1996; 139(Suppl.)53–59
   PubMedGoogle Scholar
• Beal M. F. Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 1996; 6: 661–666
   PubMed Web of Science ®Google Scholar
• Tandan R. Clinical features and differential diagnosis of classical motor neuron disease. Motor Neuron Disease, A. C. Williams. Chapman & Hall Medical, London 1994; 1–27
   Google Scholar
• Li T. M., Alberman E., Swash M. Comparison of sporadic and familial disease amongst 580 cases of motor neuron disease. J. Neurol. Neurosurg. Psychiatry 1988; 51: 778–784
   PubMed Web of Science ®Google Scholar
• Bergeron C., Petrunka C., Weyer L. Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability. Am. J. Pathol 1996; 148: 273–279
   PubMed Web of Science ®Google Scholar
• Pardo C. A., Xu Z., Borchelt D. R., Price D. L., Sisodia S. S., Cleveland D. W. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc. Natl. Acad. Sci. USA 1995; 92: 954–958
   PubMed Web of Science ®Google Scholar
• Fridovich I. Superoxide radical and superoxide dismutases. Annu. Rev. Biochem 1995; 64: 97–112
   PubMed Web of Science ®Google Scholar
• Yim M. B., Chock P. B., Stadtman E. R. Enzyme function of copper, zinc superoxide dismutase as a free radical generator. J. Biol. Chem. 1993; 268: 4099–4105
   PubMed Web of Science ®Google Scholar
• Borchelt M. R., Lee M. K., Slunt H. S., Guarnieri M., Xu Z. S., Wong P. C., Brown R. H., Price D. L., Sisodia S. S., Cleveland D. W. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA 1994; 91: 8292–8296
   PubMed Web of Science ®Google Scholar
• Bruijn L. I., Houseweart M. K., Kato S., Anderson K. L., Anderson S. D., Ohama E., Reaume A. G., Scott R. W., Cleveland D. W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 1998; 281: 1851–1854
   PubMed Web of Science ®Google Scholar
• Brown R. H. Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function. Curr. Opin. Neurobiol. 1995; 5: 841–846
   PubMed Web of Science ®Google Scholar
• Yim M. B., Kang J. H., Yim H. S., Kwak H. S., Chock P. B., Stadtman E. R. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. USA 1996; 93: 5709–5714
   PubMed Web of Science ®Google Scholar
• Volkel H., Selzle M., Walk T., Jung G., Link J., Ludolph A. C. Altered dimerisation rate and aggregation of mutated copper/zinc superoxide dismutases in amyotrophic lateral sclerosis, unpublished
   Google Scholar
• Deng H. X., Hentati A., Tainer J. A., Iqbal Z., Cayabyab A., Hung W. Y., Getzoff E. D., Hu P., Herzfeldt B., Roos R. P. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993; 261: 1047–1051
   PubMed Web of Science ®Google Scholar
• DalCanto M. C., Gurney M. E. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS). Brain Res. 1995; 676: 25–40
   PubMed Web of Science ®Google Scholar
• Reaume G., Elliott J. L., Hoffman E. K., Kowall N. W., Ferrante R. J., Siwek D. F., Wilcox H. M., Flood D. G., Beal M. F., Brown R. H., Scott R. W., Snider W. D. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet. 1995; 13: 43–47
   Web of Science ®Google Scholar
• Tu P. H., Raju P., Robinson K. A., Gurney M. E., Trojanowski J. Q., Lee V. M. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA 1996; 93: 3155–3160
   PubMed Web of Science ®Google Scholar
• Epstein C. J., Avraham K. B., Lovett M., Smith S., Elroy-Stein O., Rotman G., Bry C., Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome. Proc. Natl. Acad. Sci. USA 1987; 84: 8044–8048
   PubMed Web of Science ®Google Scholar
• Li Y., Huang T. T., Carlson E. J., Melov S., Ursell P. C., Olson J. L., Noble L. J., Yoshimura M. P., Berger C., Chan P. H. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genet. 1995; 11: 376–381
   PubMed Web of Science ®Google Scholar
• Gurney M., Cutting F. B., Zhai P., Doble A., Taylor C. P., Andrus P. K., Hall E. D. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 1996; 39: 147–158
   PubMed Web of Science ®Google Scholar
• Hottinger A., Fine E. G., Gurney M. E., Zurn A. D., Aebischer P. The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis. Eur. J. Neurosci. 1997; 9: 2548–2552
   Google Scholar
• Rothstein J. D., Jin L., Dykes-Hoberg M., Kuncl R. W. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc. Natl. Acad. Sci. USA 1993; 90: 6591–6595
   PubMed Web of Science ®Google Scholar
• Ikonomidou C., Qin Y. Qin, Labruyere J., Olney J. W. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1996; 55: 211–224
   PubMed Web of Science ®Google Scholar
• Carriedo S. G., Yin H. Z., Weiss J. H. Motor neurons are selectively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J. Neurosci. 1996; 16: 4069–4079
   PubMed Web of Science ®Google Scholar
• Morrison M., Janssen W. G.M., Gordon J. W., Morrison J. H. Light and electron microscopic distribution of the AMPA receptor subunit, GluR2, in the spinal cord of control and G86R mutant superoxide dismutase transgenic mice. J. Comp. Neurol. 1998; 395: 523–534
   PubMed Web of Science ®Google Scholar
• Feldmeyer D., Kask K., Brusa R., Kornau H.-C., Kolhekar R., Rozov A., Burnashev N., Jensen V., Hvalby O., Sprengel R., Seeburg P. H. Neurological dysfunction of mice expressing different levels of the Q/R site-unedited AMPAR subunit GluR-B. Nature Neurosci. 1999; 2: 57–64
   PubMed Web of Science ®Google Scholar
• Zuo J., De Jager P. L., Takahashi K. A., Jiang W., Linden D. J., Heintz N. Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene. Nature 1997; 388: 769–773
   PubMed Web of Science ®Google Scholar
• Rothstein J. D., Martin L. J., Kuncl R. W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 1992; 326: 1464–1468
   PubMed Web of Science ®Google Scholar
• Rothstein J. D., Van Kammen M., Levey A. I., Martin L. J., Kuncl R. W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 1995; 38: 73–84
   PubMed Web of Science ®Google Scholar
• Storck T., Schulte S., Hofmann K., Stoffel W. Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. USA 1992; 89: 10,955–10,959
   Google Scholar
• Kanai Y., Hediger M. A. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 1992; 360: 467–471
   PubMed Web of Science ®Google Scholar
• Pines G., Danbolt N. C., Bjoras M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., Kanner B. I. Cloning and expression of a rat brain L-glutamate transporter. Nature 1992; 360: 464–467
   PubMed Web of Science ®Google Scholar
• Fairman W. A., Vandenberg R. J., Arriza J. L., Kavanaugh M. P., Amara S. G. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 1995; 375: 599–604
   PubMed Web of Science ®Google Scholar
• Arriza J. L., Fairman W. A., Wadiche J. I., Murdoch G. H., Kavanaugh M. P., Amara S. G. Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 1994; 14: 5559–5569
   PubMed Web of Science ®Google Scholar
• Arriza J. L., Eliasof S., Kavanaugh M. P., Amara S. G. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. USA 1997; 94: 4155–4160
   PubMed Web of Science ®Google Scholar
• Rothstein J. D., Dykes-Hoberg M., Pardo C. A., Bristol L. A., Jin L., Kuncl R. W., Kanai Y., Hediger M. A., Wang Y., Schielke J. P., Welty D. F. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16: 675–686
   PubMed Web of Science ®Google Scholar
• Tanaka K., Watase K., Manabe T., Yamada K., Watanabe M., Takahashi K., Iwama H., Nishikawa T., Ichihara N., Kikuchi T., Okuyama S., Kawashima N., Hori S., Takimoto M., Wada K. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997; 276: 1699–1702
   PubMed Web of Science ®Google Scholar
• Masliah E., Alford M., DeTeresa R., Mallory M., Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 1996; 40: 759–766
   PubMed Web of Science ®Google Scholar
• Masliah E., Raber J., Alford M., Mallory M., Mattson M. P., Yang D., Wong D., Mucke L. Amyloid protein precursor stimulates excitatory amino acid transport. Implications for roles in neuroprotection and pathogenesis. J. Biol. Chem. 1998; 273: 12,548–12,554
   Google Scholar
• Torp R., Lekieffre D., Levy L. M., Haug F. M., Danbolt N. C., Meldrum B. S., Ottersen O. P. Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus. Exp. Brain. Res. 1995; 103: 51–58
   PubMed Web of Science ®Google Scholar
• Meyer T., Ludolph A. C., Morkel M., Hagemeier C., Speer A. Genomic organization of the human excitatory amino acid transporter gene GLT-1. NeuroReport 1997; 8: 775–777
   PubMed Web of Science ®Google Scholar
• Meyer T., Munch C., Volkel H., Booms P., Ludolph A. C. The EAAT2 (GLT-1) gene in motor neuron disease: Absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia. J. Neurol. Neurosurg. Psychiatry 1998; 65: 594–596
   PubMed Web of Science ®Google Scholar
• Aoki M., Lin C. L., Rothstein J. D., Geller B. A., Hosler B. A., Munsat T. L., Horvitz H. R., Brown R. H. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis. Ann. Neurol. 1998; 43: 645–653
   PubMed Web of Science ®Google Scholar
• Lin C. L., Bristol L. A., Jin L., Dykes-Hoberg M., Crawford T., Clawson L., Rothstein J. D. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589–602
   PubMed Web of Science ®Google Scholar
• Meyer T., Munch C., Knappenberger B., Liebau S., Volkel H., Ludolph A. C. Alternative splicing of the glutamate transporter EAAT2 (GLT-1). Neurosci. Lett. 1998; 241: 68–70
   PubMed Web of Science ®Google Scholar
• Meyer T., Munch C., Liebau S., Fromm A., Schwalenstocker B., Volkel H., Ludolph A. C. Splicing of the glutamate transporter EAAT2: A candidate gene of amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 1998; 65: 954
   PubMed Web of Science ®Google Scholar
• Nagai M., Abe K., Okamoto K., Itoyama Y. Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci. Lett. 1998; 244: 165–168
   PubMed Web of Science ®Google Scholar
• Meyer T., Lenk U., Kuther G., Weindl A., Speer A., Ludolph A. C. Studies of the coding region of the neuronal glutamate transporter gene in amyotrophic lateral sclerosis. Ann. Neurol. 1995; 37: 817–819
   PubMed Web of Science ®Google Scholar
• Munch C., Schwalenstocker B., Knappenberger B., Liebau S., Volkel H., Ludolph A. C., Meyer T. 5′-heterogeneity of the human excitatory amino acid transporter cDNA EAAT2 (GLT-1). NeuroReport 1998; 9: 1295–1297
   PubMed Web of Science ®Google Scholar
• Utsunomiya-Tate N., Endou H., Kanai Y. Tissue specific variants of glutamate transporter GLT-1. FEBS Lett. 1997; 416: 312–316
   PubMed Web of Science ®Google Scholar
• Wong P. C., Pardo C. A., Borchelt D. R., Lee M. K., Copeland N. G., Jenkins N. A., Sisodia S. S., Cleveland D. W., Price D. L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105–1116
   PubMed Web of Science ®Google Scholar
• Gurney M. E., Pu H., Chiu A. Y., Canto M. C. Dal, Polchow C. Y., Alexander D. D., Caliendo J., Hentati A., Kwon Y. W., Deng H. X. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994; 264: 1772–1775
   PubMed Web of Science ®Google Scholar
• White R. J., Reynolds I. J. Mitochondrial depolarization in glutamate-stimulated neurons: An early signal specific to excitotoxin exposure. J. Neurosci. 1996; 16: 5688–5697
   PubMed Web of Science ®Google Scholar
• Schinder A. F., Olson E. C., Spitzer N. C., Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 1996; 16: 6125–6133
   PubMed Web of Science ®Google Scholar